$GBLX #OTCQB GB Sciences, Inc. (GBLX: OTCQB) | GB Sciences Completes and Achieves Statistical Significance in Preclinical Study of Its Proprietary Parkinson’s Disease Cannabinoid Formulations and Begins Mechanism of Action Study With the National Research Council of Canada
Copyright 2019 – OTC Markets Group Inc.

News Link